Solid Biosciences Inc (SLDB)
10.18
-0.06
(-0.63%)
USD |
NASDAQ |
May 03, 16:00
10.18
0.00 (0.00%)
After-Hours: 16:14
Solid Biosciences Research and Development Expense (Quarterly): 15.45M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.45M |
| September 30, 2023 | 16.70M |
| June 30, 2023 | 19.78M |
| March 31, 2023 | 24.63M |
| December 31, 2022 | 21.29M |
| September 30, 2022 | 14.00M |
| June 30, 2022 | 23.18M |
| March 31, 2022 | 19.94M |
| December 31, 2021 | 14.60M |
| September 30, 2021 | 14.42M |
| June 30, 2021 | 15.51M |
| March 31, 2021 | 14.21M |
| December 31, 2020 | 15.72M |
| September 30, 2020 | 16.04M |
| June 30, 2020 | 13.45M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.66M |
| December 31, 2019 | 27.07M |
| September 30, 2019 | 22.79M |
| June 30, 2019 | 21.61M |
| March 31, 2019 | 23.27M |
| December 31, 2018 | 17.76M |
| September 30, 2018 | 14.68M |
| June 30, 2018 | 13.59M |
| March 31, 2018 | 11.93M |
| December 31, 2017 | 11.95M |
| September 30, 2017 | 10.62M |
| June 30, 2017 | 8.607M |
| March 31, 2017 | 8.733M |
| December 31, 2016 | 7.068M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
13.45M
Minimum
Jun 2020
27.07M
Maximum
Dec 2019
18.42M
Average
16.70M
Median
Sep 2023
Research and Development Expense (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 200.40M |
| PTC Therapeutics Inc | 116.13M |
| Capricor Therapeutics Inc | 9.940M |
| Perspective Therapeutics Inc | 6.08M |
| Electromed Inc | 0.107M |